Timik Group is a Nordic healthcare company that focuses on medical equipment for diagnosing, treating and management of acute and chronic diseases.

Timik Group

Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain. This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities. This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

Eduard Fresenius

Fresenius SE & Co. KGaA

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG & Co. KGaA

Medtech Nordic offers an AI operating system designed for the future of diagnostics. The company is self-described as focusing on innovative solutions in the medtech sector.

Medtech Nordic

Timik Group AB | 1,784 followers on LinkedIn. Improving lives in the Nordics  | Timik Group is a Nordic medtech distributor that focuses on medical equipment for diagnosing, treating and management of acute and chronic diseases. We have extensive experience in finding innovative and reliable medical technology and distribute it to our customers across the Nordic region.

Our focus areas are Anesthesia, Ventilation, Neonatal Care, Infusion, Drug Delivery, Pre-hospital, Pulmonary Diagnostics &amp; Cardiology, Sleep &amp; Homecare Ventilation, Sport Science, Rehabilitation and Test Equipment.

CEO at Insplorion AB

Johan Rask

Business Development Director - Nordic at Timik Group

Tomas Andersen

Managing Director Timik ApS – A member of Timik Group AB

Ole Hansen

Field Sales Manager at Timik AB

Thomas Brixander

Timik Group AB

Today is World Diabetes Day, a crucial reminder that over 500 million people live with diabetes, and nearly half are unaware of their condition. Let's raise awareness and promote early detection! #TimikMedical #TimikGroup #WorldDiabetesDay #AtellicaDCA #DiabetesAwareness

We are happy to have Filip Schönbeck on our team, and confident he will guide our company towards new heights. Here’s to a successful journey together and exciting achievements ahead! #TimikMedical #TimikGroup #NewCEO

🚀Our Swedish office are currently searching for a Service Engineer 🚀 If you have any questions, please don't be hesitant to ask! We would love to connect with you. Apply now! https://lnkd.in/dU89SqJc #TimikMedical #TimikGroup #ServiceEngineer #MedTech #Hiring

Siemens Healthineers is showcasing their cutting-edge Point of Care portfolio at EUSEM in Copenhagen. We warmly invite you to visit them at Booth no. 16. Explore innovative offerings and discover how this can support your healthcare needs. See you there for engaging discussions and opportunities to enhance patient care! Timik Group AB is also present at booth 16, to be your go-to contact for all Siemens Healthineers Point of Care solutions in the Nordic region. #EUSEM #EmergencyMedicine #SiemensHealthineers #TimikGroup

Timik ApS attending at the DMTS landsmøde event in Vejle! We're eager to showcase our latest advancements in medical technology, designed to enhance healthcare delivery. Please visit our stand to explore innovative solutions and discuss. See you there! #TimikMedical #TimikGroup #MedTech #MedicalTechnology

Welcome you to our stand at the DEKS Congress in Kolding. Explore our Point of Care (POC) portfolio from Siemens Healthineers and discover solutions that enhance patient care and diagnostics. Don't miss the opportunity to connect with our POC team. See you there! #TimikGroup #TimikMedical #PointofCare #POC

Join our partner Siemens Healthineers for a must-attend webinar on the POC High-Sensitivity Troponin 0-2 Hour Rapid Algorithm. Discover how the Atellica VTLi revolutionizes cardiology with proven safety and effectiveness. Secure your spot now! https://lnkd.in/eyPhBxQA #TimikGroup #TimikMedical #Cardiology #Innovation

We are excited to announce that Timik Group AB are currently participating in the Nordic Congress in Clinical Chemistry 2024 at the Karolinska Institutet, Sweden. Visit us at our stand to discover the latest innovations and technologies in the field. This is a prime opportunity to engage with our experts and explore how our solutions enhance patient care. Looking forward to meeting you there! If you want to learn more about TIMIK Group and our products for point of care diagnostics, take a look at http://www.timikgroup.com #TimikGroup #TimikMedical #PointofCare #POC

Timik AB is excited to attend the SFAI Congress in Helsingborg, September 18-20! We warmly welcome you to visit our stand to explore, have insightful discussions and new collaborations! Visit our stand SFAI Congress in Helsingborg from September 18-20. We welcome you to visit our stand to explore our latest innovations in medical technology. Look forward seeing you! #TimikGroup #TimikMedical #SFAI2024

A quick glimpse of last week's kick-off at Lejondals Slott in Sweden. Timik Group AB is proud of our amazing team across the Nordics, now fully energized to go for the benefit of all our customers and patients! #TimikGroup #TimikMedical #KickOff

Metric
Company Name	Timik Group	Fresenius SE & Co. KGaA	Fresenius Medical Care AG & Co. KGaA	Medtech Nordic
Symbol		FRE	FME
MSH ID	COM:TIMIKGROUP	COM:FRESENIUS	COM:FRESENIUSMEDICALCARE	COM:MEDTECHNORDIC
Market	PRIVATE	STOCKS	STOCKS	PRIVATE
Sector	Healthcare & Health Services	Healthcare	Healthcare	Healthcare & Health Services
Industry	Medical Equipment	Medical - Care Facilities	Medical - Care Facilities	Medical Technology
Country	SE	DE	DE	SE
Stage		Post-IPO Equity
Employee Count		190.86K	117.13K
Website	timikgroup.com	fresenius.com	freseniusmedicalcare.com	medtechnordic.com
LinkedIn	timik-group-ab	fresenius-se	fresenius-medical-care-italia-spa	nordic-medtech-ab
Founders

Metric
Market Cap	17.24B	11.22B
Enterprise Value
Monthly Web Traffic	69.89K
Web Traffic Growth	-0.27
Valuation
Raised Capital

Metric
Revenue	23.55B	20.55B
Revenue (LTM)
Revenue (NTM)
Gross Profit	5.34B	5.20B
EBITDA	2.88B	3.63B
Operating Income	1.21B	1.58B
Net Income	-627.40M	527.06M
EPS	-1.11	1.80
Diluted EPS	-1.11	1.80
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.23	0.25
Operating Profit Margin	0.06	0.08
EBITDA Margin	0.12	0.18
Net Profit Margin	-0.02	0.03
Return on Equity	-0.03	0.04
Return on Assets	-0.01	0.02
Return on Capital Employed	0.05	0.06

COM:TIMIKGROUP

Timik Group

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	52.33	19.14
P/B Ratio	0.72	0.75
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.87	0.63
EV Multiple	2.69	0.95

Metric
Days Sales Outstanding	374.30	69.66
Days Payables Outstanding	15.95	21.21
Days Inventory Outstanding	56.49	56.09
Operating Cycle	141.96	132.45
Cash Conversion Cycle	113.50	112.72
Asset Turnover	0.70	0.62

Metric
Operating Cash Flow	4.71B	2.78B
Free Cash Flow	3.51B	2.05B
Cash Flow to Debt	0.34	0.34
Operating Cash Flow/Sales	0.18	0.16
Free Cash Flow Yield	0.20	0.16

Metric
Cash & Equivalents	2.42B	1.48B
Accounts Receivable	-278.84M	-160.38M
Inventory	2.66B	2.30B
Goodwill	15.94B	15.47B
Debt to Capitalization	0.45	0.47
Debt to Assets	0.20	0.36
Current Ratio	1.54	1.37
Quick Ratio	1.04	1.14

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		-0.02
R&D to Revenue	0.02	0.01
SG&A to Revenue	0.13